Cargando…
Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain
Background: Chronic non-cancer pain (CNCP) is estimated to affect 20% of the adult population. Current United States and Canadian Chronic non-cancer pain guidelines recommend careful reassessment of the risk-benefit ratio for doses greater than 90 mg morphine equivalent dose (MED), due to low eviden...
Autores principales: | MacCallum, Caroline A., Eadie, Lauren, Barr, Alasdair M., Boivin, Michael, Lu, Shaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120104/ https://www.ncbi.nlm.nih.gov/pubmed/33995035 http://dx.doi.org/10.3389/fphar.2021.633168 |
Ejemplares similares
-
Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
por: Eadie, Lauren, et al.
Publicado: (2021) -
A Clinical Framework for Evaluating Cannabis Product Quality and Safety
por: MacCallum, Caroline A., et al.
Publicado: (2023) -
Risks of harm with cannabinoids, cannabis, and cannabis-based medicine for pain management relevant to patients receiving pain treatment: protocol for an overview of systematic reviews
por: Gilron, Ian, et al.
Publicado: (2019) -
Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments
por: Yau, Jade C., et al.
Publicado: (2019) -
A Clinical Framework for Assessing Cannabis-Related Impairment Risk
por: MacCallum, Caroline A., et al.
Publicado: (2022)